Clinical trial
A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma
NCT00020683 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00020683 |
|---|---|
| Title | A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma |
| Official title | A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | AIDS-related Kaposi Sarcoma, HIV Infection |
| Intervention type | Drug, Other |
| Interventions | incyclinide, laboratory biomarker analysis |
| Enrollment | 70 |
| Start date | Mar 1, 2003 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: